Biogen’s Aduhelm Competitors Boosted By Final CMS Coverage Decision

Eisai, Roche, Lilly Will Have Efficacy Data Much Sooner

rear view of asian senior man sitting outdoors in wheelchair
Medicare coverage of Aduhelm remains restricted to Alzheimer's patients in clinical trials • Source: Alamy

More from Drug Pricing

More from Scrip